Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
32,982,385
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
29,784,935
-
Shares change
-
+863,746
-
Total reported value, excl. options
-
$3,901,788,451
-
Value change
-
+$121,585,155
-
Put/Call ratio
-
311%
-
Number of buys
-
133
-
Number of sells
-
-134
-
Price
-
$131.01
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2019
326 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2019.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,784,935 shares
of 32,982,385 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4,320,856 shares), VANGUARD GROUP INC (3,184,115 shares), WELLINGTON MANAGEMENT GROUP LLP (1,880,203 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,491,598 shares), JPMORGAN CHASE & CO (1,012,874 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,012,582 shares), STATE STREET CORP (1,009,576 shares), ALLIANCEBERNSTEIN L.P. (850,092 shares), DIMENSIONAL FUND ADVISORS LP (818,322 shares), and RIVERBRIDGE PARTNERS LLC (669,017 shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.